TAUG - Tauriga Sciences Inc. to Resume the Clinical Development of its Proposed Anti-Nausea Pharmaceutical Grade Version of Tauri-Gum
Snapshot of U.S. Patent Assignment / PTAS (# 506080043)
Link your Twitter Account to Market Wire News
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
home / news releases / TAUG - Tauriga Sciences Inc. to Resume the Clinical Development of its Proposed Anti-Nausea Pharmaceutical Grade Version of Tauri-Gum
Stock Information
Get TAUG Alerts
News, Short Squeeze, Breakout and More Instantly...